Loading your research…

Opening the latest published company and exchange records.

EarningsCanvas Company research, closer to the source.

Source health MembershipAll times IST

NSE · NSE SME · BSE

Live market announcements

Results, orders and company updates, with a trail back to the filing. Check the feed status below for freshness.

3 / 3Exchange feeds checked

Other disclosuresBSE · 524804

Aurobindo Pharma Ltd

Aurobindo Pharma Ltd - 524804 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Published 5 Oct 2026, 13:11 ISTOpen source filing

01 / The disclosure

What the company shared

Submission of certificate in terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.

Exchange-provided summary Company profile

A question for your research

Read the underlying filing for the complete disclosure and any conditions not included in the exchange summary.

Disclosed period ended 2026-09-30 · Q2 FY2027

The evidence

Read the source excerpts

Exchange listing available

PDF text extraction is queued. The summary above comes from the exchange listing.

Source & verificationView the disclosure trail

Summary method: Exchange-provided text; no generated financial figures
Exchange identifier: 53420804-dc4b-49d7-ade7-84f03c1d348b
First collected: 5 Oct 2026, 13:59 IST
PDF extraction: pending

Official exchange listing

You’ve reached the end of this disclosure.